Results 131 to 140 of about 16,883 (239)

Development of quantitative HPTLC methods for dolutegravir, lamivudine, and tenofovir disproxil fumarate in a combination pharmaceutical product using a model process published earlier for transfer of minilab TLC screening methods to HPTLC-densitometry [PDF]

, 2019
Yiru Gu, Bingsong Zeng, J. Sherma
openalex   +1 more source

Real-World Experience with Dolutegravir-Based Two-Drug Regimens [PDF]

, 2020
Douglas Ward, Moti Ramgopal, David J. Riedel, Cindy Garris, Shelly Dhir, John Waller, Jenna Roberts, Katie Mycock, Alan Oglesby, Collins Bonnie, Megan Dominguez, James Pike, Joseph Mrus   +12 more
openalex   +1 more source

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States [PDF]

, 2021
Karin M. Butler, Sarah‐Jane Anderson, Olivia Hayward, I. Jacob, Yogesh Punekar, Lee Evitt, Alan Oglesby   +6 more
openalex   +1 more source

Computational Studies for Selected Medicinal Plants against Dolutegravir using Ligand Based Pharmacophore, Molecular Docking, ADMET Predictionsand Molecular Dynamics Simulation [PDF]

, 2022
Andrew Rabontsi Motsilanyane, Zimbili Mkhize, Sphelele C. Sosibo   +2 more
openalex   +1 more source

A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens. [PDF]

J Antimicrob Chemother
Dickinson L, Else L, Venter WDF, Boffito M, Brand R, Waitt C, Hill A, Khoo S.   +7 more
europepmc   +1 more source

EP-167 - EFEITO DA TERAPIA ANTIRRETROVIRAL APÓS SWITCH PARA DOLUTEGRAVIR SOBRE O PESO E O ÍNDICE DE MASSA CORPORAL ENTRE PESSOAS VIVENDO COM HIV, SALVADOR - BAHIA

Marina Possídio, Monaliza Cardozo Rebouças, Fabianna Bahia, Beatriz Tejo Dantas, Leonardo Bandeira Cerqueira Zollinger, Ana Carolina G.B. Menezes   +5 more
openalex   +1 more source

Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1

, 2023
Prina Donga, Bruno Émond, Carmine Rossi, Brahim Bookhart, Johnnie Lee, Gabrielle Caron‐Lapointe, Fangzhou Wei, Marie‐Hélène Lafeuille   +7 more
openalex   +2 more sources

Reduced Metformin Concentrations in Obese Women With Human Immunodeficiency Virus Treated With Dolutegravir. [PDF]

J Infect Dis
van Rensburg R, Kellermann T, Pillay-Fuentes Lorente V, du Plessis C, Orrell C, Maposa I, Schreuder C, Jennings L, van Zyl G, Schifitto G, Decloedt E.   +10 more
europepmc   +1 more source

Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry [PDF]

Filippo Lagi, Michele Bellomo, Riccardo Lolatto, Filippo Ducci, Seble Tekle Kiros, Vincenzo Spagnuolo, Rebecka Papaioannu Borjesson, Tommaso Clemente, Leonardo Calza, Marcello Feasi, Emanuele Focà, Andrea Giacomelli, Roberto Gulminetti, Barbara Menzaghi, Antonella Castagna, on behalf of the PRESTIGIO Study Group   +15 more
openalex   +1 more source

Prevalence and factors associated with hyperglycemia among children living with HIV on dolutegravir in Kabale district, southwestern Uganda. [PDF]

PLoS One
Idow LH, Nduhukire T, Ankunda S, Tumwesigire S, Nyeko F, Tumwine JK.   +5 more
europepmc   +1 more source